Electromed (ELMD) Change in Accured Expenses (2010 - 2026)
Electromed's (ELMD) quarterly Change in Accured Expenses came in at $1.7 million in Q1 2026, up 44.64% year-on-year from $1.1 million in Q1 2025, and up 191.35% on a QoQ basis from -$1.8 million in Q4 2025.
Electromed (ELMD) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Electromed (ELMD) has 17 years of Change in Accured Expenses data on file, last reported at $1.7 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 44.64% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $600000.0, a 66.35% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, up 35.54% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $1.7 million, up from -$1.8 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for ELMD reached as high as $1.7 million in Q1 2026 and fell as low as -$1.8 million in Q4 2025.
- Historically, Change in Accured Expenses has averaged $265117.6 across 5 years, with a median of $448000.0 in 2025.
- Across the five-year window, Change in Accured Expenses jumped 1291.18% in 2022 and tumbled 3219.23% in 2023, its largest moves.
- Year by year, Change in Accured Expenses stood at -$685000.0 in 2022, then surged by 55.04% to -$308000.0 in 2023, then sank by 249.35% to -$1.1 million in 2024, then tumbled by 68.77% to -$1.8 million in 2025, then surged by 191.35% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $1.7 million in Q1 2026, -$1.8 million in Q4 2025, and $448000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Electromed | 325.66 Mn | 308.67 Mn | 14.64 Mn | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | 448,000.00 |
| Sep 30, 2025 | 448,000.00 |
| Jun 30, 2025 | 309,000.00 |
| Jun 30, 2025 | 309,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | 806,000.00 |
| Sep 30, 2024 | 806,000.00 |
| Jun 30, 2024 | 906,000.00 |
| Jun 30, 2024 | 906,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | -308,000.00 |
| Dec 31, 2023 | -308,000.00 |